These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 368879)

  • 1. The fibrinolytic system--basic considerations.
    Castellino FJ; Violand BN
    Prog Cardiovasc Dis; 1979; 21(4):241-54. PubMed ID: 368879
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
    Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of EACA, PAMBA, AMCA and AMBOCA on fibrinolysis induced by streptokinase, urokinase and tissue activator.
    Westlund LE; Lundén R; Wallén P
    Haemostasis; 1982; 11(4):235-41. PubMed ID: 6982199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary thrombolysis: pharmacological considerations with emphasis on tissue-type plasminogen activator (t-PA).
    Fox KA; Bergmann SR; Sobel BE
    Biochem Pharmacol; 1984 Jun; 33(12):1831-8. PubMed ID: 6233982
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinogen-fibrin related antigen pattern in human blood. Incomplete lysis of whole blood clots by urokinase.
    Jacobsen CD; Fry GL; Wu KK; Southers NJ
    Thromb Res; 1975 Apr; 6(4):327-36. PubMed ID: 1079637
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasminogen-plasmin system. 3. Kinetics of plasminogen activation and inhibition of plasminogen-plasmin system by some synthetic inhibitors.
    Iwamoto M; Abiko Y; Shimizu M
    J Biochem; 1968 Dec; 64(6):759-67. PubMed ID: 4238017
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of efficacy of thrombolysin, streptokinase, and urokinase in a femoral vein clot model in rats.
    Cooley BC; Jones MM; Dellon AL
    Microsurgery; 1983; 4(1):1-4. PubMed ID: 6226846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of 3,4,5-trimethoxybenzoyl-epsilon-amino caproic acid on platelet aggregation and on the activation of plasminogen by streptokinase.
    Rognoni F; Garzia A; Ariano M
    Atherosclerosis; 1971; 14(3):375-8. PubMed ID: 5135230
    [No Abstract]   [Full Text] [Related]  

  • 9. The inhibitory effect of plasma inhibitor on plasmin activated with streptokinase or urokinase.
    Sumi H; Takada Y; Takada A
    Nihon Seirigaku Zasshi; 1977; 39(5):112-4. PubMed ID: 72149
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK).
    Lipinski B; Gurewich V; Hyde E
    Thromb Diath Haemorrh; 1975 Sep; 34(1):351. PubMed ID: 1188799
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolytic agents.
    Schmitz-Huebner U; van de Loo J
    Clin Haematol; 1981 Jun; 10(2):481-96. PubMed ID: 7032785
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacology of fibrinolysis.
    Haire WD
    Chest; 1992 Apr; 101(4 Suppl):91S-97S. PubMed ID: 1555484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative ex vivo study of plasminogen activators and proteases for fibrinolytic activity and side effects in rabbits.
    Janik BA; Papaioannou SE
    Thromb Haemost; 1977 Feb; 37(1):154-61. PubMed ID: 576512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biphasic inhibition of urokinase-induced fibrinolysis by epsilon-aminocaproic acid; distinction from tissue plasminogen activator.
    Thorsen S; Astrup T
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):811-3. PubMed ID: 5773672
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor XIII cross-linking and the rate of fibrinolysis induced by streptokinase and urokinase.
    Rampling MW
    Thromb Res; 1978 Feb; 12(2):287-95. PubMed ID: 635844
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
    Skoza L; Tse AO; Semar M; Johnson AJ
    Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440
    [No Abstract]   [Full Text] [Related]  

  • 17. The activation and inhibition of fibrinolysis.
    Castellino FJ; Schick LA; Brockway WJ; Sodetz JM
    Adv Exp Med Biol; 1975; 63():233-43. PubMed ID: 128278
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro measurement of fibrinolysis by urokinase].
    Senf L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):819-21. PubMed ID: 6176506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthetic compounds with fibrinolytic and thrombolytic activity. I. Pharmacologic observations].
    Desnoyers P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):351-6. PubMed ID: 63421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.